Significance of Vitamin Supplementation in Reducing the Severity of COVID-19
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Coronavirus disease-19 (COVID-19), a serious pandemic due to the SARS-CoV-2 virus infection, caused significant lockdowns, healthcare shortages, and deaths worldwide. The infection leads to an uncontrolled systemic inflammatory response causing severe respiratory distress and multiple-organ failure. Quick development of several vaccines efficiently controlled the spread of COVID-19. However, the rise of various new subvariants of COVID-19 demonstrated some concerns over the efficacy of existing vaccines. Currently, better vaccines to control these variants are still under development as several new subvariants of COVID-19, such as omicron BA-4, BA-5, and BF-7 are still impacting the world. Few antiviral treatments have been shown to control COVID-19 symptoms. Further, control of COVID-19 symptoms has been explored with many natural and synthetic adjuvant compounds in hopes of treating the deadly and contagious disease. Vitamins have been shown to modulate the immune system, function as antioxidants, and reduce the inflammatory response. Recent studies have investigated the potential role of vitamins, specifically vitamins A, B, C, D, and E, in reducing the immune and inflammatory responses and severity of the complication. In this brief article, we discussed our current understanding of the role of vitamins in controlling COVID-19 symptoms and their potential use as adjuvant therapy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
Mini reviews in medicinal chemistry - 24(2024), 3 vom: 26., Seite 254-264 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Aiges, Myia [VerfasserIn] |
---|
Links: |
---|
Themen: |
11103-57-4 |
---|
Anmerkungen: |
Date Completed 30.01.2024 Date Revised 30.01.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/1389557523666230324081713 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM35472522X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM35472522X | ||
003 | DE-627 | ||
005 | 20240130232002.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/1389557523666230324081713 |2 doi | |
028 | 5 | 2 | |a pubmed24n1275.xml |
035 | |a (DE-627)NLM35472522X | ||
035 | |a (NLM)36967461 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Aiges, Myia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Significance of Vitamin Supplementation in Reducing the Severity of COVID-19 |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 30.01.2024 | ||
500 | |a Date Revised 30.01.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a Coronavirus disease-19 (COVID-19), a serious pandemic due to the SARS-CoV-2 virus infection, caused significant lockdowns, healthcare shortages, and deaths worldwide. The infection leads to an uncontrolled systemic inflammatory response causing severe respiratory distress and multiple-organ failure. Quick development of several vaccines efficiently controlled the spread of COVID-19. However, the rise of various new subvariants of COVID-19 demonstrated some concerns over the efficacy of existing vaccines. Currently, better vaccines to control these variants are still under development as several new subvariants of COVID-19, such as omicron BA-4, BA-5, and BF-7 are still impacting the world. Few antiviral treatments have been shown to control COVID-19 symptoms. Further, control of COVID-19 symptoms has been explored with many natural and synthetic adjuvant compounds in hopes of treating the deadly and contagious disease. Vitamins have been shown to modulate the immune system, function as antioxidants, and reduce the inflammatory response. Recent studies have investigated the potential role of vitamins, specifically vitamins A, B, C, D, and E, in reducing the immune and inflammatory responses and severity of the complication. In this brief article, we discussed our current understanding of the role of vitamins in controlling COVID-19 symptoms and their potential use as adjuvant therapy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Vitamins | |
650 | 4 | |a adjuvant therapy | |
650 | 4 | |a immunity | |
650 | 4 | |a inflammation | |
650 | 4 | |a severe respiratory distress. | |
650 | 7 | |a Vitamins |2 NLM | |
650 | 7 | |a Vitamin A |2 NLM | |
650 | 7 | |a 11103-57-4 |2 NLM | |
650 | 7 | |a Vitamin K |2 NLM | |
650 | 7 | |a 12001-79-5 |2 NLM | |
650 | 7 | |a Vaccines |2 NLM | |
700 | 1 | |a Ramana, Kota V |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Mini reviews in medicinal chemistry |d 2001 |g 24(2024), 3 vom: 26., Seite 254-264 |w (DE-627)NLM121595404 |x 1875-5607 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2024 |g number:3 |g day:26 |g pages:254-264 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/1389557523666230324081713 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2024 |e 3 |b 26 |h 254-264 |